Category

• Pipeline2

Organizations

• Bausch + Lomb64
• Alcon, Inc.43
• Eyes On Eyecare43
• American Optometric Association34
• Harrow28
• Glaukos26
• Regeneron22
• Topcon Healthcare22
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• Cornea2
• Cataract Surgery1
• Corneal Dystrophy1
• Corneal Ulcer1

• Organizations: Trefoil Therapeutics✕

Clear all

Pipeline

Phase 2 data of TTHX1114 shows promise for improving post-DSO visual recovery rate

Trefoil Therapeutics’ first investigational FGF-1 improved BCVA and CCT.

Pipeline

First patient dosed in phase 1 study for CED treatment

Trial is assessing Trefoil Therapeutics’ lead investigational candidate: TTHX114.